Reuters: Regulatory News: PRESS DIGEST-New York Times business news - June 3

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

PRESS DIGEST-New York Times business news - June 3 Jun 3rd 2013, 05:33 June 3 | Mon Jun 3, 2013 1:33am EDT June 3 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * Government officials, drug companies and medical experts are considering options to speed development of medicines to combat infections that have developed resistance to available countermeasures. () * The Justice Department's lawsuit that accuses Apple Inc of colluding with publishers to raise e-book prices will begin this week. () * Steven Cohen's SAC Capital Advisors faces billions of dollars in withdrawals from investors by a Monday deadline, as over the next several weeks authorities decide whether to bring a criminal case against the hedge fund related to suspicious trading in two drug stocks. () * In a highly unusual move, the Food and Drug Administration has decided to reopen the case on GlaxoSmithKline's diabetes pill Avandia and will ask a committee whether it should reconsider the restrictions on the drug. * Behind the bid for Smithfield Foods, America's biggest pork producer, was a group of savvy investors and global deal makers who hold a substantial stake in the Chinese company. () * MSNBC experienced a ratings decline in the last two months as viewers turned away from politics. ()

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions